100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2010 Research Grants

Mark Davis, Ph.D.
Developing Targeted Nanoparticles to Interfere with K-ras Expression using siRNA
California Institute pf Technology

Christopher M. Counter, Ph. D.
Evaluating the Therapeutic Advantage of Adding L-NAME to the Treatment Modality of Erlontinib and Gemcitabine
Duke University 

Samir Hanash, M.D., Ph.D.

James Marks, M.D., Ph.D.
James DeCaprio, M.D.
Biomarker Initiative Phase II Validation
Fred Hutchinson Cancer Research Center
University of California, San Francisco
Dana-Farber Cancer Institute

William Matsui, M.D.
Regulation of Pancreatic Cancer Self-Renewal and Metastasis by the Tumor Microenvironment
Johns Hopkins University

Cesar Castro, M.D.
Ralph Weissleder, M.D., Ph.D.
Imaging Pancreatic Ductal Adenocarcinoma via Novel Cathepsin E Imaging Agents
Massachusetts General Hospital

Charles Fuchs, M.D.
Matthew Vander Heiden, M.D., Ph. D.
Aims to Identify Differences in Metabolism Between Pancreatic Cancer Cells and Normal Cells
Massachsetts General Hospital

Frank McCormick, Ph.D., FRS., DSc.
Interfering with K-ras Espressing using siRNA Against K-ras in targeted nanoparticles
University of California, San Francisco

Stephen Fesik, Ph.D.
Direct Targeting of K-ras with Small Molecules
Vanderbilt University

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303